These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 47883)

  • 1. South-to-north gradient in distribution of the r determinant of hepatitis B surface antigen in Japan.
    Yamishita Y; Kurashina S; Miyakawa Y; Mayumi M
    J Infect Dis; 1975 May; 131(5):567-9. PubMed ID: 47883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of hepatitis B surface antigen in Southeast Asia.
    Snitbhan R; Scott RM; Bancroft WH; Top FH; Chiewsilp D
    J Infect Dis; 1975 Jun; 131(6):708-11. PubMed ID: 48531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed haemagglutination tests for the detection of hepatitis B antigen.
    Schuurs AH; Kacaki J
    Vox Sang; 1974; 27(2):97-114. PubMed ID: 4212322
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of the paired label radioantibody technique to detection and subtyping of hepatitis B surface antigen.
    Miyakawa Y; Imai M; Mayumi M
    J Immunol; 1975 Mar; 114(3):1135-7. PubMed ID: 46262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtypes of hepatitis B surface antigen in familial clusters of hepatitis B virus carriers.
    Kashiwagi S; Hayashi J; Nomura H; Ikematsu H; Shingu T; Hayashida K; Yamashita Y; Kaji M
    Am J Epidemiol; 1983 Dec; 118(6):795-8. PubMed ID: 6650480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemagglutination inhibition assay of the common determinants and subspecificities of Australia antigen.
    Imai M; Yamashita Y; Miyakawa Y; Mayumi M
    Immunology; 1974 Nov; 27(5):871-8. PubMed ID: 4140156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new haemagglutination technique for the demonstration of hepatitis-B antigen.
    Reesink HW; Duimel WJ; Brummelhuis HG
    Lancet; 1973 Dec; 2(7842):1351-3. PubMed ID: 4128053
    [No Abstract]   [Full Text] [Related]  

  • 8. A new virus specified determinant of hepatitis B surface antigen.
    Magnius L; Kaplan L; Vyas GN; Perkins HA
    Acta Pathol Microbiol Scand B; 1975 Jun; 83(3):295-7. PubMed ID: 50717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.
    Magnius LO; Espmark JA
    J Immunol; 1972 Nov; 109(5):1017-21. PubMed ID: 4116763
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of dane particles with e antigen in the serum of asymptomatic carriers of hepatitis B surface antigen.
    Takahashi K; Imai M; Tsuda F; Takahashi T; Miyakawa Y
    J Immunol; 1976 Jul; 117(1):102-5. PubMed ID: 819577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An agglutination-flocculation test for rapid detection of hepatitis B antigen.
    Kachani ZF; Gocke DJ
    J Immunol; 1973 Nov; 111(5):1564-70. PubMed ID: 4200781
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B surface antigen with an excess or deficiency in subtypic determinants in sera from asymptomatic carriers in Japan.
    Tachibana K; Tanaka T; Usuda S; Okamoto H; Tsuda F; Akahane Y; Miyakawa Y; Mayumi M
    Viral Immunol; 1989; 2(1):25-9. PubMed ID: 2472809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of hepatitis B antigen among patients and symptomless carriers.
    Green HT; Turner GC
    J Hyg (Lond); 1975 Feb; 74(1):123-31. PubMed ID: 46235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and persistence of "Australia" antigen determinants.
    Schmidt NJ; Roberto RR; Lennette EH
    Infect Immun; 1972 Jul; 6(1):1-4. PubMed ID: 4117699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australia antigen: persistence of immunological markers (d, y, w) in antigen carriers.
    Mazzur S; Blumberg BS
    Infect Immun; 1973 Aug; 8(2):178-81. PubMed ID: 4125265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody.
    Brummelhuis HG
    Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of frequency of Australia antigen in blood donors of Tokyo by means of immune adherence hemagglutination technique.
    Okochi K; Mayumi M; Haguino Y; Saito N
    Vox Sang; 1970; 19(3):332-7. PubMed ID: 4993785
    [No Abstract]   [Full Text] [Related]  

  • 18. Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits.
    Gerin JL; Faust RM; Holland PV
    J Immunol; 1975 Jul; 115(1):100-5. PubMed ID: 50341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination.
    Tsuda F; Takahashi T; Takahashi K; Miyakawa Y; Mayumi M
    J Immunol; 1975 Sep; 115(3):834-8. PubMed ID: 1171142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B surface antigen: regional variation in sub-type ratio in the Canadian Red Cross donor population.
    Valet JP; Matte J; O'Connell AP; Duravetz J
    Can Med Assoc J; 1975 May; 112(10):1179-80, 1183. PubMed ID: 47783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.